Head-Up; An interdisciplinary,participatory and co-design process informing the development of a novel head and neck support for people living with progressive neck muscle weakness

Abstract

This paper presents the Head-Up project, that aims to provide innovative head support to help improve posture, relieve pain and aid communication for people living with progressive neck muscle weakness. The initial focus is motor neurone disease. The case study illustrates collaborative, interdisciplinary research and new product development underpinned by participatory design. The study was initiated by a 2-day stakeholder workshop followed by early proof-of-concept modelling and patient need evidence building. The work subsequently led to a successful NIHR i4i application funding a 24-month iterative design process, patenting, CE marking and clinical evaluation. The evaluation has informed amendments to the proposed design refered to here as the Sheffield Support Snood (SSS). The outcome positively demonstrates use and performance improvements over current neck orthoses and the process of multidisciplinary and user engagement has created a sense of ownership by MND participants, who have since acted as advocates for the product.     

医学文献资源共享与服务模式创新之实现

介绍佛山市医院图书馆发展现状,指出佛山市医院图书馆存在的主要问题,提出实现区域医学文献资源共享的构想,并就网络环境下信息服务模式的创新进行探讨。     

Reviewing the Nutrition and Health Claims Regulation (EC) No. 1924/2006: What do we know about its challenges and potential impact on innovation?

Health claims potentially represent an opportunity for firms to engage in product differentiation and thereby induce investment into R&D and innovation in the food sector. The Nutrition and Health Claims Regulation (EC) No. 1924/2006 (NHCR) aims at protecting and promoting innovation as one of its objectives. However, existing studies indicate that this regulation may create several challenges for innovation in the food sector. To this end, we review the challenges related to the NHCR (Article 13.1) and its impact on innovation. Extant literature suggests that companies face challenges related to changing list of ingredients, missing transparency, wording of claims, limited financial resources, limited R&D resources, switching product categories and abandoning the functional foods sector. Moreover, current studies imply that so far the NHCR (in specific Article 13.1) does not seem to encourage innovation in the EU food sector.     

网络环境下的新农合管理信息系统的应用与体会

本文对新农合管理信息系统的功能应用进行了分析和探讨。按照新农合管理信息系统字典库的要求,完善我院HIS系统中的医疗服务项目、药品目录字典等内容,保障新农合管理信息系统在我院畅通运行。     

开放式创新与我国生物医药产业的创新路径

创新能力是生物医药产业核心竞争能力的重要内容。文章探讨了阻碍我国生物医药产业创新能力提升的主要因素,在研究开放式创新模式的基础上,考虑将开放式创新纳入我国生物医药产业创新的可能,并从四个方面提出了开放式创新环境下我国生物医药企业持续提升创新能力的创新路径：制定开放式创新战略,参与全球技术创新联盟,强化多层次的创新主体和构筑产业开放式创新的多向支撑。     

The Risks of Innovation in Health Care

Innovation in health care creates risks that are unevenly distributed. An evolutionary analogy using species to represent business models helps categorize innovation experiments and their risks. This classification reveals two qualitative categories: early and late diversification experiments. Early diversification has prolific innovations with high risk because they encounter a “decimation” stage, during which most experiments disappear. Participants face high risk. The few decimation survivors can be sustaining or disruptive according to Christensen’s criteria. Survivors enter late diversification, during which they again expand, but within a design range limited to variations of the previous surviving designs. Late diversifications carry lower risk. The exception is when disruptive survivors “diversify,” which amplifies their disruption. Health care and radiology will experience both early and late diversifications, often simultaneously. Although oversimplifying Christensen’s concepts, early diversifications are likely to deliver disruptive innovation, whereas late diversifications tend to produce sustaining innovations. Current health care consolidation is a manifestation of late diversification. Early diversifications will appear outside traditional care models and physical health care sites, as well as with new science such as molecular diagnostics. They warrant attention because decimation survivors will present both disruptive and sustaining opportunities to radiology. Radiology must participate in late diversification by incorporating sustaining innovations to its value chain. Given the likelihood of disruptive survivors, radiology should seriously consider disrupting itself rather than waiting for others to do so. Disruption entails significant modifications of its value chain, hence, its business model, for which lessons may become available from the pharmaceutical industry’s current simultaneous experience with early and late diversifications.     

脊柱源性疾病学理论与技术研创述要

总结笔者18年来脊柱源性疾病学的研究述要，包括理论研究和技术创新。其理论研究：①提出、论证大脊柱概念、人体脊椎中心论和“全息失衡标志-脊柱-脏器疾病相关”学说；②揭示脊柱源性疾病的概念内涵与发病机制；③建立脊柱源性疾病的人文整体诊疗观念；④建构脊柱源性疾病学的学科框架。其技术创新：①发明多维全息诊查法、人体斑痣诊测法；②研创脊柱源性病症的“身-心-灵-境”四维解析法；③研发三步针罐疗法、三维调神针法等系列新技术；④建构集预防、治疗和康复于一体的“脊柱源性疾病单元疗法”。综上基本形成了脊柱医学的新学科、新流派，具有重大理论与临床意义。